Table of Contents 1 Dilated Cardiomyopathy Therapeutic Market Overview 1.1 Product Overview and Scope of Dilated Cardiomyopathy Therapeutic 1.2 Classification of Dilated Cardiomyopathy Therapeutic by Types 1.2.1 Global Dilated Cardiomyopathy Therapeutic Revenue Comparison by Types (2019-2024) 1.2.2 Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Types in 2018 1.2.3 Aldosterone antagonists 1.2.4 Angiotensin-converting enzyme (ACE) inhibitors 1.2.5 Angiotensin II receptor blockers (ARBs) 1.2.6 Beta-blockers 1.3 Global Dilated Cardiomyopathy Therapeutic Market by Application 1.3.1 Global Dilated Cardiomyopathy Therapeutic Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Hospitals 1.3.3 Academic Institutions 1.4 Global Dilated Cardiomyopathy Therapeutic Market by Regions 1.4.1 Global Dilated Cardiomyopathy Therapeutic Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Dilated Cardiomyopathy Therapeutic Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Dilated Cardiomyopathy Therapeutic Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Dilated Cardiomyopathy Therapeutic Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Dilated Cardiomyopathy Therapeutic Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Dilated Cardiomyopathy Therapeutic Status and Prospect (2014-2024) 1.5 Global Market Size of Dilated Cardiomyopathy Therapeutic (2014-2024) 2 Company Profiles 2.1 Novartis International AG 2.1.1 Business Overview 2.1.2 Dilated Cardiomyopathy Therapeutic Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Novartis International AG Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) 2.2 Pfizer, Inc. 2.2.1 Business Overview 2.2.2 Dilated Cardiomyopathy Therapeutic Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Pfizer, Inc. Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) 2.3 GlaxoSmithKline plc 2.3.1 Business Overview 2.3.2 Dilated Cardiomyopathy Therapeutic Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 GlaxoSmithKline plc Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) 2.4 AstraZeneca plc. 2.4.1 Business Overview 2.4.2 Dilated Cardiomyopathy Therapeutic Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 AstraZeneca plc. Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) 2.5 Array BioPharma, Inc. 2.5.1 Business Overview 2.5.2 Dilated Cardiomyopathy Therapeutic Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Array BioPharma, Inc. Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) 2.6 Celladon Corporation 2.6.1 Business Overview 2.6.2 Dilated Cardiomyopathy Therapeutic Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Celladon Corporation Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) 2.7 Teva Pharmaceutical Industries Ltd. 2.7.1 Business Overview 2.7.2 Dilated Cardiomyopathy Therapeutic Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Teva Pharmaceutical Industries Ltd. Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) 2.8 Merck & Co., Inc. 2.8.1 Business Overview 2.8.2 Dilated Cardiomyopathy Therapeutic Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Merck & Co., Inc. Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) 2.9 Janssen Pharmaceuticals, Inc. (J&J) 2.9.1 Business Overview 2.9.2 Dilated Cardiomyopathy Therapeutic Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Janssen Pharmaceuticals, Inc. (J&J) Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) 2.10 Sanofi S.A. 2.10.1 Business Overview 2.10.2 Dilated Cardiomyopathy Therapeutic Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Sanofi S.A. Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) 2.11 Vericel Corporation 2.11.1 Business Overview 2.11.2 Dilated Cardiomyopathy Therapeutic Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Vericel Corporation Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) 3 Global Dilated Cardiomyopathy Therapeutic Market Competition, by Players 3.1 Global Dilated Cardiomyopathy Therapeutic Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Dilated Cardiomyopathy Therapeutic Players Market Share 3.2.2 Top 10 Dilated Cardiomyopathy Therapeutic Players Market Share 3.3 Market Competition Trend 4 Global Dilated Cardiomyopathy Therapeutic Market Size by Regions 4.1 Global Dilated Cardiomyopathy Therapeutic Revenue and Market Share by Regions 4.2 North America Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 4.3 Europe Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 4.5 South America Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 5 North America Dilated Cardiomyopathy Therapeutic Revenue by Countries 5.1 North America Dilated Cardiomyopathy Therapeutic Revenue by Countries (2014-2019) 5.2 USA Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 5.3 Canada Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 5.4 Mexico Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 6 Europe Dilated Cardiomyopathy Therapeutic Revenue by Countries 6.1 Europe Dilated Cardiomyopathy Therapeutic Revenue by Countries (2014-2019) 6.2 Germany Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 6.3 UK Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 6.4 France Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 6.5 Russia Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 6.6 Italy Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Dilated Cardiomyopathy Therapeutic Revenue by Countries 7.1 Asia-Pacific Dilated Cardiomyopathy Therapeutic Revenue by Countries (2014-2019) 7.2 China Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 7.3 Japan Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 7.4 Korea Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 7.5 India Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 8 South America Dilated Cardiomyopathy Therapeutic Revenue by Countries 8.1 South America Dilated Cardiomyopathy Therapeutic Revenue by Countries (2014-2019) 8.2 Brazil Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 8.3 Argentina Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 8.4 Colombia Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Dilated Cardiomyopathy Therapeutic by Countries 9.1 Middle East and Africa Dilated Cardiomyopathy Therapeutic Revenue by Countries (2014-2019) 9.2 Saudi Arabia Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 9.3 UAE Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 9.4 Egypt Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 9.5 Nigeria Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 9.6 South Africa Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) 10 Global Dilated Cardiomyopathy Therapeutic Market Segment by Type 10.1 Global Dilated Cardiomyopathy Therapeutic Revenue and Market Share by Type (2014-2019) 10.2 Global Dilated Cardiomyopathy Therapeutic Market Forecast by Type (2019-2024) 10.3 Aldosterone antagonists Revenue Growth Rate (2014-2024) 10.4 Angiotensin-converting enzyme (ACE) inhibitors Revenue Growth Rate (2014-2024) 10.5 Angiotensin II receptor blockers (ARBs) Revenue Growth Rate (2014-2024) 10.6 Beta-blockers Revenue Growth Rate (2014-2024) 11 Global Dilated Cardiomyopathy Therapeutic Market Segment by Application 11.1 Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Application (2014-2019) 11.2 Dilated Cardiomyopathy Therapeutic Market Forecast by Application (2019-2024) 11.3 Hospitals Revenue Growth (2014-2019) 11.4 Academic Institutions Revenue Growth (2014-2019) 12 Global Dilated Cardiomyopathy Therapeutic Market Size Forecast (2019-2024) 12.1 Global Dilated Cardiomyopathy Therapeutic Market Size Forecast (2019-2024) 12.2 Global Dilated Cardiomyopathy Therapeutic Market Forecast by Regions (2019-2024) 12.3 North America Dilated Cardiomyopathy Therapeutic Revenue Market Forecast (2019-2024) 12.4 Europe Dilated Cardiomyopathy Therapeutic Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Dilated Cardiomyopathy Therapeutic Revenue Market Forecast (2019-2024) 12.6 South America Dilated Cardiomyopathy Therapeutic Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Dilated Cardiomyopathy Therapeutic Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Dilated Cardiomyopathy Therapeutic Picture Table Product Specifications of Dilated Cardiomyopathy Therapeutic Table Global Dilated Cardiomyopathy Therapeutic and Revenue (Million USD) Market Split by Product Type Figure Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Types in 2018 Figure Aldosterone antagonists Picture Figure Angiotensin-converting enzyme (ACE) inhibitors Picture Figure Angiotensin II receptor blockers (ARBs) Picture Figure Beta-blockers Picture Table Global Dilated Cardiomyopathy Therapeutic Revenue (Million USD) by Application (2014-2024) Figure Dilated Cardiomyopathy Therapeutic Revenue Market Share by Applications in 2018 Figure Hospitals Picture Figure Academic Institutions Picture Table Global Market Dilated Cardiomyopathy Therapeutic Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Dilated Cardiomyopathy Therapeutic Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Dilated Cardiomyopathy Therapeutic Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Dilated Cardiomyopathy Therapeutic Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Dilated Cardiomyopathy Therapeutic Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Dilated Cardiomyopathy Therapeutic Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Dilated Cardiomyopathy Therapeutic Revenue (Million USD) and Growth Rate (2014-2024) Table Novartis International AG Basic Information, Manufacturing Base and Competitors Table Novartis International AG Dilated Cardiomyopathy Therapeutic Type and Applications Table Novartis International AG Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) Table Pfizer, Inc. Basic Information, Manufacturing Base and Competitors Table Pfizer, Inc. Dilated Cardiomyopathy Therapeutic Type and Applications Table Pfizer, Inc. Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) Table GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors Table GlaxoSmithKline plc Dilated Cardiomyopathy Therapeutic Type and Applications Table GlaxoSmithKline plc Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) Table AstraZeneca plc. Basic Information, Manufacturing Base and Competitors Table AstraZeneca plc. Dilated Cardiomyopathy Therapeutic Type and Applications Table AstraZeneca plc. Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) Table Array BioPharma, Inc. Basic Information, Manufacturing Base and Competitors Table Array BioPharma, Inc. Dilated Cardiomyopathy Therapeutic Type and Applications Table Array BioPharma, Inc. Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) Table Celladon Corporation Basic Information, Manufacturing Base and Competitors Table Celladon Corporation Dilated Cardiomyopathy Therapeutic Type and Applications Table Celladon Corporation Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) Table Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors Table Teva Pharmaceutical Industries Ltd. Dilated Cardiomyopathy Therapeutic Type and Applications Table Teva Pharmaceutical Industries Ltd. Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors Table Merck & Co., Inc. Dilated Cardiomyopathy Therapeutic Type and Applications Table Merck & Co., Inc. Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) Table Janssen Pharmaceuticals, Inc. (J&J) Basic Information, Manufacturing Base and Competitors Table Janssen Pharmaceuticals, Inc. (J&J) Dilated Cardiomyopathy Therapeutic Type and Applications Table Janssen Pharmaceuticals, Inc. (J&J) Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) Table Sanofi S.A. Basic Information, Manufacturing Base and Competitors Table Sanofi S.A. Dilated Cardiomyopathy Therapeutic Type and Applications Table Sanofi S.A. Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) Table Vericel Corporation Basic Information, Manufacturing Base and Competitors Table Vericel Corporation Dilated Cardiomyopathy Therapeutic Type and Applications Table Vericel Corporation Dilated Cardiomyopathy Therapeutic Revenue, Gross Margin and Market Share (2017-2018) Table Global Dilated Cardiomyopathy Therapeutic Revenue (Million USD) by Players (2014-2019) Table Global Dilated Cardiomyopathy Therapeutic Revenue Share by Players (2014-2019) Figure Global Dilated Cardiomyopathy Therapeutic Revenue Share by Players in 2017 Figure Global Dilated Cardiomyopathy Therapeutic Revenue Share by Players in 2018 Figure Global Top 5 Players Dilated Cardiomyopathy Therapeutic Revenue Market Share in 2018 Figure Global Top 10 Players Dilated Cardiomyopathy Therapeutic Revenue Market Share in 2018 Figure Global Dilated Cardiomyopathy Therapeutic Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Dilated Cardiomyopathy Therapeutic Revenue (Million USD) by Regions (2014-2019) Table Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Regions (2014-2019) Figure Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Regions (2014-2019) Figure Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Regions in 2018 Figure North America Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure Europe Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure South America Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Table North America Dilated Cardiomyopathy Therapeutic Revenue by Countries (2014-2019) Table North America Dilated Cardiomyopathy Therapeutic Revenue Market Share by Countries (2014-2019) Figure North America Dilated Cardiomyopathy Therapeutic Revenue Market Share by Countries (2014-2019) Figure North America Dilated Cardiomyopathy Therapeutic Revenue Market Share by Countries in 2018 Figure USA Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure Canada Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure Mexico Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Table Europe Dilated Cardiomyopathy Therapeutic Revenue (Million USD) by Countries (2014-2019) Figure Europe Dilated Cardiomyopathy Therapeutic Revenue Market Share by Countries (2014-2019) Figure Europe Dilated Cardiomyopathy Therapeutic Revenue Market Share by Countries in 2018 Figure Germany Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure UK Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure France Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure Russia Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure Italy Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Table Asia-Pacific Dilated Cardiomyopathy Therapeutic Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Dilated Cardiomyopathy Therapeutic Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Dilated Cardiomyopathy Therapeutic Revenue Market Share by Countries in 2018 Figure China Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure Japan Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure Korea Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure India Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure Southeast Asia Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Table South America Dilated Cardiomyopathy Therapeutic Revenue by Countries (2014-2019) Table South America Dilated Cardiomyopathy Therapeutic Revenue Market Share by Countries (2014-2019) Figure South America Dilated Cardiomyopathy Therapeutic Revenue Market Share by Countries (2014-2019) Figure South America Dilated Cardiomyopathy Therapeutic Revenue Market Share by Countries in 2018 Figure Brazil Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure Argentina Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure Colombia Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Table Middle East and Africa Dilated Cardiomyopathy Therapeutic Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Dilated Cardiomyopathy Therapeutic Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Dilated Cardiomyopathy Therapeutic Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Dilated Cardiomyopathy Therapeutic Revenue Market Share by Countries in 2018 Figure Saudi Arabia Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure UAE Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure Egypt Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure Nigeria Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Figure South Africa Dilated Cardiomyopathy Therapeutic Revenue and Growth Rate (2014-2019) Table Global Dilated Cardiomyopathy Therapeutic Revenue (Million USD) by Type (2014-2019) Table Global Dilated Cardiomyopathy Therapeutic Revenue Share by Type (2014-2019) Figure Global Dilated Cardiomyopathy Therapeutic Revenue Share by Type (2014-2019) Figure Global Dilated Cardiomyopathy Therapeutic Revenue Share by Type in 2018 Table Global Dilated Cardiomyopathy Therapeutic Revenue Forecast by Type (2019-2024) Figure Global Dilated Cardiomyopathy Therapeutic Market Share Forecast by Type (2019-2024) Figure Global Aldosterone antagonists Revenue Growth Rate (2014-2019) Figure Global Angiotensin-converting enzyme (ACE) inhibitors Revenue Growth Rate (2014-2019) Figure Global Angiotensin II receptor blockers (ARBs) Revenue Growth Rate (2014-2019) Figure Global Beta-blockers Revenue Growth Rate (2014-2019) Table Global Dilated Cardiomyopathy Therapeutic Revenue by Application (2014-2019) Table Global Dilated Cardiomyopathy Therapeutic Revenue Share by Application (2014-2019) Figure Global Dilated Cardiomyopathy Therapeutic Revenue Share by Application (2014-2019) Figure Global Dilated Cardiomyopathy Therapeutic Revenue Share by Application in 2018 Table Global Dilated Cardiomyopathy Therapeutic Revenue Forecast by Application (2019-2024) Figure Global Dilated Cardiomyopathy Therapeutic Market Share Forecast by Application (2019-2024) Figure Global Hospitals Revenue Growth Rate (2014-2019) Figure Global Academic Institutions Revenue Growth Rate (2014-2019) Figure Global Dilated Cardiomyopathy Therapeutic Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Dilated Cardiomyopathy Therapeutic Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Dilated Cardiomyopathy Therapeutic Revenue Market Share Forecast by Regions (2019-2024) Figure North America Dilated Cardiomyopathy Therapeutic Revenue Market Forecast (2019-2024) Figure Europe Dilated Cardiomyopathy Therapeutic Revenue Market Forecast (2019-2024) Figure Asia-Pacific Dilated Cardiomyopathy Therapeutic Revenue Market Forecast (2019-2024) Figure South America Dilated Cardiomyopathy Therapeutic Revenue Market Forecast (2019-2024) Figure Middle East and Africa Dilated Cardiomyopathy Therapeutic Revenue Market Forecast (2019-2024)

Novartis International AG Pfizer, Inc. GlaxoSmithKline plc AstraZeneca plc. Array BioPharma, Inc. Celladon Corporation Teva Pharmaceutical Industries Ltd. Merck & Co., Inc. Janssen Pharmaceuticals, Inc. (J&J) Sanofi S.A. Vericel Corporation